NGeneBio Co Ltd
354200
Company Profile
Business description
NGeneBio Co Ltd is engaged in the business of developing companion diagnosis, disease diagnosis, and liquid biopsy products and bioinformatics software. The company manufactures and sells NGS-based precision diagnostic products.
Contact
288, Digital-ro
Units 303, 304, 305, 306, 307, 1st floor, Jebi 127, 1st floor, Jebi 128
Guro-dong, Daeryung Post Tower 1
Guro-gu
Seoul
KORT: +82 28679798
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
57
Stocks News & Analysis
stocks
Coca-Cola earnings: Innovation and brand strength underpin growth
We plan to raise our fair value estimate of Coca-Cola stock.
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,288.10 | 43.80 | -0.47% |
| CAC 40 | 8,258.86 | 52.79 | 0.64% |
| DAX 40 | 24,330.03 | 71.23 | 0.29% |
| Dow JONES (US) | 46,924.74 | 218.16 | 0.47% |
| FTSE 100 | 9,426.99 | 23.42 | 0.25% |
| HKSE | 25,679.83 | 347.72 | -1.34% |
| NASDAQ | 22,953.67 | 36.88 | -0.16% |
| Nikkei 225 | 49,102.72 | 213.34 | -0.43% |
| NZX 50 Index | 13,325.02 | 52.83 | -0.39% |
| S&P 500 | 6,735.35 | 0.22 | 0.00% |
| S&P/ASX 200 | 9,001.50 | 38.80 | -0.43% |
| SSE Composite Index | 3,899.05 | 17.28 | -0.44% |